Maze Therapeutics to Participate in Two Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Jul 10, 2025
SOUTH SAN FRANCISCO, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular diseases, today announced that company management will participate in fireside chats during two upcoming investor conferences in July:
Read more at globenewswire.com
